Lyka Labs Limited (BOM:500259)
63.57
+0.44 (0.70%)
At close: Jul 24, 2026
Lyka Labs Revenue
In the fiscal year ending March 31, 2026, Lyka Labs had annual revenue of 1.25B INR, down -7.27%. Lyka Labs had revenue of 244.11M in the quarter ending March 31, 2026, a decrease of -17.39%.
Revenue
1.25B
Revenue Growth
-7.27%
P/S Ratio
1.79
Revenue / Employee
1.93M
Employees
648
Market Cap
2.23B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.25B | -97.91M | -7.27% |
| Mar 31, 2025 | 1.35B | 284.33M | 26.78% |
| Mar 31, 2024 | 1.06B | 167.66M | 18.75% |
| Mar 31, 2023 | 894.17M | -950.50M | -51.53% |
| Mar 31, 2022 | 1.84B | 1.16B | 169.25% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambalal Sarabhai Enterprises | 2.03B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.97B |
| Gennex Laboratories | 1.73B |
| Astonea Labs | 1.48B |
| Kerala Ayurveda | 1.31B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |
Lyka Labs News
- 1 year ago - Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn
- 1 year ago - Lyka Labs secures patent for Pregabalin Gel 8% to treat diabetic neuropathic pain - Business Upturn